The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalExpert Opinion on Pharmacotherapy
Volume20
Issue number5
Pages (from-to)501-510
ISSN1744-7666
DOIs
Publication statusPublished - 2019

    Research areas

  • Exenatide extended-release, exenatide QW, glucagon-like peptide 1, glucagon-like peptide 1 receptor agonist, glycaemic control, type 2 diabetes, cardiovascular adverse events

ID: 226114209